| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin
|
Vanderlinden, Evelien
|
|
|
196 |
C |
p.
|
article
|
| 2 |
Characterization of a thiourea derivative that targets viral transactivators of cytomegalovirus and herpes simplex virus type 1
|
Kondo, Hiroki
|
|
|
196 |
C |
p.
|
article
|
| 3 |
Determination of infectious hepatitis B virus particles by an end-point dilution assay identifies a novel class of inhibitors
|
Jo, Eunji
|
|
|
196 |
C |
p.
|
article
|
| 4 |
Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies
|
Qiu, Hongyu
|
|
|
196 |
C |
p.
|
article
|
| 5 |
Editorial Board
|
|
|
|
196 |
C |
p.
|
article
|
| 6 |
2-((1H-indol-3-yl)thio)-N-phenyl-acetamides: SARS-CoV-2 RNA-dependent RNA polymerase inhibitors
|
Zhao, Jianyuan
|
|
|
196 |
C |
p.
|
article
|
| 7 |
Identification of Ascomycin against Zika virus infection through screening of natural product library
|
Zhou, Liang
|
|
|
196 |
C |
p.
|
article
|
| 8 |
JNJ-64794964 (AL-034/TQ-A3334), a TLR7 agonist, induces sustained anti-HBV activity in AAV/HBV mice via non-cytolytic mechanisms
|
Herschke, Florence
|
|
|
196 |
C |
p.
|
article
|
| 9 |
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein
|
Svilenov, Hristo L.
|
|
|
196 |
C |
p.
|
article
|
| 10 |
75 years of bovine viral diarrhea virus: Current status and future applications of the use of directed antivirals
|
Newcomer, Benjamin W.
|
|
|
196 |
C |
p.
|
article
|
Journal description